Phoenix Holdings Ltd. Galmed Pharmaceuticals Ltd. Transaction History

Phoenix Holdings Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$3.06 - $4.17 $446,346 - $608,257	-145,865 Closed	0 $0
Q3 2020 Nov 10, 2020	BUY	$3.46 - $5.69 $39,568 - $65,070	11,436 Added 8.51%	145,865 $480,000
Q2 2020 Aug 10, 2020	BUY	$3.22 - $6.08 $190,128 - $358,999	59,046 Added 78.33%	134,429 $611,000
Q1 2020 May 20, 2020	BUY	$3.3 - $6.84 $188,522 - $390,755	57,128 Added 312.94%	75,383 $253,000
Q4 2019 Feb 18, 2020	SELL	$3.61 - $6.75 $25,338 - $47,378	-7,019 Reduced 27.77%	18,255 $105,000

Q3 2019 Nov 18, 2019	BUY	$4.62 - $7.11 $116,765 - $179,698	25,274 New	25,274 $115,000

Ticker GLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,088,400
Market Cap $7.02M
Description
Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or t...

Get notified when there are updates to the investment portfolio of Phoenix Holdings Ltd., based on Form 13F filings with the SEC.

Stay updated on Phoenix Holdings Ltd. with notifications on news.